Onconetix ONCO 深 滬
等待開盤 11-04 09:30:00 美东时间
0.569
+0.026
+4.83%
華盛通- 最 高0.5695
- 今 開0.5426
- 成交量 64.37万股
- 最 低 0.515
- 昨 收 0.5428
- 總市值 298.24万
- 52周最高 161.00
- 市盈率 靜 --
- 換手率 12.28%
- 52周最低 0.3423
- 委 比 -20.00%
- 總股本 524.15万
- 歷史最高 15453000.00
- 量 比 0.06
- 振 幅 10.04%
- 歷史最低 0.3423
- 每 手 1
- 風險率 45.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Onconetix announces second major reverse stock split
Onconetix ( ($ONCO) ) has issued an update. On April 30, 2026, Onconetix stockh...
10-27 05:29
Onconetix Announces 1-For-10 Reverse Stock Split Effective On November 6, 2026
Onconetix, Inc. (NASDAQ:ONCO) (the "Company"), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common stock. The reverse split is expected to become effective at 12:01 a.m. Eastern Time on November 6, 2026. The Compan...
10-27 05:05
Onconetix Announces Reverse Stock Split
Onconetix, Inc. announced a 1-for-10 reverse stock split of its outstanding common stock, effective November 6, 2026. This will reduce the number of shares from approximately 5.89 million to 588,677, with no change to shareholders' percentage ownership or par value. Fractional shares will be settled in cash. The stock will continue trading on Nasdaq under the symbol "ONCO" with a new CUSIP number, 68237Q500. The reverse split will adjust options,...
10-26 21:03
Onconetix Makes Additional Advance Of $500K To Realbotix Under Strategic Bridge Financing Facility
Additional $500,000 Advance to Support Growth Initiatives and Working Capital of Realbotix LLC Total Drawn Under Facility Now $3,000,000; Non-Interest Bearing Facility Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition CINCINNATI, Ohio, Oct. 23, 2026 (GLOBE NEWSWIRE) ...
10-23 20:33
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
Onconetix, Inc. has provided an additional $500,000 to Realbotix LLC under a strategic bridge financing facility, bringing the total advanced to $3,000,000. The facility is non-interest bearing until the completion of the pending acquisition, at which point it will be automatically canceled. If the acquisition is terminated, interest will accrue at 12% per annum. Onconetix and Realbotix aim to combine operations, with the combined company expecte...
10-23 12:30
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX Global Inc. has updated shareholders on the liquidation of Vistagen Therapeutics and Greenland Mines, and added an investment in Onconetix Inc. (ONCO) in anticipation of its acquisition of Realbotix LLC. Realbotix's Vinci AI Vision System, featuring robotic eyeballs with embedded cameras and tracking lenses, enables facial recognition, object detection, and emotional analysis. SRX believes the technology is undervalued and has significant pot...
09-24 16:30
Onconetix shares are trading lower. The company announced a strategic bridge financing facility of up to $5 million to Realbotix.
Onconetix shares are trading lower. The company announced a strategic bridge financing facility of up to $5 million to Realbotix.
09-15 01:23
Onconetix Secures Bridge Financing for Realbotix Acquisition
An update from Onconetix ( ($ONCO) ) is now available. On September 11, 2026, O...
09-14 23:17
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Onconetix, Inc. has provided a $5 million strategic bridge financing facility to Realbotix LLC, with an initial $2.5 million advance, to support its growth and working capital needs. The non-interest-bearing facility will be automatically canceled upon closing of the pending acquisition. The acquisition, announced in February 2026, involves Onconetix acquiring 100% of Realbotix's equity in an all-stock transaction, subject to shareholder approval...
09-14 16:50
